Paychex, Inc. (PAYX) Market Cap & Valuation Ratios
Paychex, Inc. (PAYX) has a market cap of $42.0B, a trailing P/E of 23.4 and a price-to-sales ratio of 6.4, with earnings according to EquiReason's reading of its SEC filings.
Source: SEC EDGAR filings · figures as of 2026-08-31 · read by EquiReason
PAYXPaychex, Inc.Follow PAYX — free
—
Price chart with a free account
- Market cap
- 42.0B
- P/E TTM
- 23.4
- Dividend yield
- 3.8%
- 52-week
- —
- Next earnings
- 17 Dec, in 54 days
Peers
software - application · nearest by market cap · trailing 12 months| Company | Mkt cap, $B | P/E | EV/Sales | EV/EBITDA | FCF yield | Rev. growth | Op. margin | ROIC |
|---|---|---|---|---|---|---|---|---|
| PAYX | 42 | 23.4 | 6.9 | 15.1 | 4.7% | +14% | 39% | 26% |
| INTU | 92 | 20.7 | 4.4 | 14.1 | 9.4% | +14% | 27% | 20% |
| CDNS | 87 | 62.9 | 15.1 | 42.1 | 1.9% | +15% | 30% | 21% |
| TEAM | 58 | — | 8.7 | 379.9 | 2.3% | +26% | 0.2% | 1% |
| MSTR | 56 | — | 121.1 | — | -0.1% | +8% | — | -79% |
| ADSK | 53 | 32.7 | 6.7 | 23.2 | 5.4% | +18% | 26% | 53% |
| WDAY | 51 | 42.5 | 4.9 | 34.6 | 5.6% | +13% | 11% | 11% |
| ROP | 43 | 18.1 | 6.6 | 16.8 | 5.9% | +11% | 28% | 7% |
| ZM | 28 | 8.9 | 4.2 | 15.8 | 6.9% | +5% | 24% | 10% |
| PTC | 21 | 18.9 | 7.5 | 18.2 | 4.4% | +19% | 38% | 20% |
| SSNC | 19 | 23.9 | 4.1 | 11.7 | 7.7% | +9% | 24% | 9% |
| Median of these 10 | 22.3 | 6.6 | 18.2 | 5.5% | +14% | 26% | 10% |
P/E 23.4 vs. a peer median of 22.3; EV/Sales 6.9 vs. 6.6. PAYX's own P/E sits at the 11th percentile of its history.
Growth vs. price
each dot a company · hover or tap for valuesTEAM and MSTR have no P/E (earnings not positive) and are left out · hover or tap a dot for values.
Paychex, Inc. — questions
- What is Paychex, Inc.'s market cap?
- $42.0B.
- What is Paychex, Inc.'s P/E ratio?
- 23.4 on trailing twelve-month earnings to 2026-08-31.
- What is Paychex, Inc.'s price-to-sales ratio?
- 6.4.
Every figure on this page comes from Paychex, Inc.'s own SEC filings — see them on SEC EDGAR. Price data is licensed and shown only inside the product.
How these figures are read: methodology · EquiReason.